VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Ensure Surgery Immunonutrition Shake
Phase 1
Small molecule
B
Boston Medical Center
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Critical Limb Ischemia
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Critical Limb Ischemia
Phase 1
Recruiting
Clinical
Trials by Indication
[1]
Critical Limb Ischemia
1 trial
Perioperative Nutritional Optimization in Patients With Critical Limb Ischemia
Recruiting
·
B
Boston Medical Center
·
Phase 1
·
NCT03529019
·
30 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Ensure Surgery Immunonutrition Shake. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Ensure Surgery Immunonutrition Shake compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Ensure Surgery Immunonutrition Shake. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Boston Medical Center company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 1
[1]
Company
B
Boston Medical Center
Related News